25(OH)D was Correlated with Increased Risk of Insulin Resistance, but Not Mediated by Adiponectin and hsCRP

Anggi Kartikawati, Yani Lina, Andi Wijaya


BACKGROUND: Studies have shown that change of calcium and vitamin D homeostasis is associated with insulin resistance, decreased beta cell function, metabolic syndrome, glucose intolerance and diabetes. Evidence suggests that vitamin D insufficiency is inversely related to risk of metabolic disorders including type-2 Diabetes Mellitus (T2DM), although the underlying mechanisms are not yet understood. Hence, current study was conducted to investigate correlation between 25(OH)D and insulin resistance through adiponectin or High Sensitivity C-Reactive Protein (hsCRP) in centrally obese men.

METHODS: This was a cross-sectional study involving 80 centrally obese men with waist circumference (WC) >90 cm and age 30-60 years. Total 25(OH)D concentration was measured by Enzyme-Linked Immunosorbent Assay (ELISA) method. Insulin resistance was calculated by HOMA model.

RESULTS: This study showed there was no correlation of 25(OH)D-WC (r=0.006 and p=0.957), 25(OH)D-adiponectin (r=0.179 and p=0.111) abd 25(OH)D-hsCRP (r=-0.223 and p=0.334), but we observed  statistically significant negative correlation between 25(OH)D and insulin resistance index (HOMA-IR) (r=0.461 and p=0.041).

CONCLUSIONS: We conclude that low 25(OH)D concentration was significantly associated with increased risk of insulin resistance. Since  the adiponectin or hsCRP was not correlated, the possible pathways need to be futher investigated.

KEYWORDS: central obesity, 25(OH)D, adiponectin, hsCRP, insulin resistance (HOMA-IR)

Full Text:



James WP. The epidemiology of obesity: The size of the problem. J Intern Med. 2008; 263: 336-52, CrossRef.

Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: A review. World J Diabetes. 2010; 1: 76-88, CrossRef.

Pischon T, Rimm EB. Adiponectin: A promising marker for cardiovascular disease. Clin Chem. 2006; 52: 797-9, CrossRef.

Von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia and heart failure in patients with coronary heart disease. Clin Chem. 2006; 52: 853-9, CrossRef.

Brannon PM, Yetley EA, Bailey RL, Picciano MF. Overview of the conference "Vitamin D and Health in the 21st Century: an Update". Am J Clin Nutr. 2008; 88: 483-90, PMID.

Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008; 57: 2619-25, CrossRef.

Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D1. J Nutr. 2005; 135: 317-22, PMID.

Grimnes G, Figenschau Y, Almas B, Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids. Diabetes. 2011; 60: 2748-57, CrossRef.

Matthews, Hosker JP, Rudenski AS, Naylor BA, Treacher, Turner RC. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985; 28: 412-9, CrossRef.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-81, CrossRef.

Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009; 32: 1278-83, CrossRef.

Wood RJ. Vitamin D and adipogenesis: New molecular insights. Nutr Rev. 2008; 66: 40-6, CrossRef.

Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-dihydroxyvitamin D improved the free fatty-acid induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008; 24: 459-64, CrossRef.

Von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2009; 103: 549-55, CrossRef.

Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease: A review of evidence. Diabetes Metab. 2005; 31: 318-25, CrossRef.

Pittas A, Joseph lau, Frank BH, Hughes D. Review: The role of vitamin D and calcium in type 2 diabetes: A systematic review and meta-analysis. Endocrinol Metab. 2007; 92: 2017-29, CrossRef.

Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: Its etiology, effects and treatment. CMAJ. 2007; 176: 1113- 20, CrossRef.

Davis SV. Vitamin D deficiency and type 2 diabetes in African Americans: The common denominators. diabetes. 2011; 24: 148-53, CrossRef.

Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol. 2009; 307: 77-82, CrossRef.

DOI: https://doi.org/10.18585/inabj.v4i2.166

Copyright (c) 2012 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute